web analytics
License Technologies   //   Disclose an Invention

Get Started with the Polsky Center

Featured

Where Are They Now? Beacon Takes Aim at Eliminating Airborne Transmission

Read More
See All Podcasts
Where Are They Now? Beacon Takes Aim at Eliminating Airborne Transmission
1 / 1
Where Are They Now? Beacon Takes Aim at Eliminating Airborne Transmission

3 Novel Disease-Fighting Technologies You Should Know About Ahead of BIO 2022

Researchers at the University of Chicago have developed methods to increase the clinical efficacy of immunotherapies, provide long-lasting immune tolerance for autoimmune or transplantation therapy, and treat breast and ovarian…

‘You Need a Village’: Clinical Trial Leaders Discuss Collaborations, COVID, and Widening the Lens

Experts came together on Clinical Trials Day to discuss why early and frequent discussions among all stakeholders are necessary, how COVID forced the industry to think “more clearly and…

OrisDX Wins 2022 New Venture Challenge with Saliva Test to Diagnose Oral Cancers

UPDATE: The investment totals have been updated to reflect additional investment made in the days following the winner announcement. A startup developing saliva-based diagnostics to screen for oral cancers and…

UChicago Ranks Among Top 25 Institutions for Tech Transfer and Commercialization

A recent analysis entitled Research to Renewal: Advancing University Tech Transfer from Heartland Forward evaluated which universities are most adept at creating new knowledge and embedding it in their graduates…

10 Teams Participate in Polsky’s Spring 2022 I-Corps Program to Refine Market Fit for Novel Tech

Ten teams from across the University of Chicago were selected to participate in the spring 2022 I-Corps program with the goal of determining the commercial potential of their technologies. Supported…

Cancer Detection, Oil Spill Cleanup, Quantum Computing, and a New Medical Device: Meet the Spring 2022 Innovation Fund Finalists

Four teams have been selected as finalists for the George Shultz Innovation Fund spring 2022 investment cycle – bringing to the forefront solutions for scaling quantum computers, sustainably cleaning oil…

UChicago Spinout Super.tech Acquired by Quantum Ecosystem Leader ColdQuanta

A University of Chicago quantum software spinout and Duality Cohort 1 participant, Super.tech has been acquired by a global quantum ecosystem leader, ColdQuanta. Super.tech is embedded in Argonne National Laboratory's…

DeepTechU Day 3: Advice for Deep Tech Entrepreneurs, the Future of Immunotherapy, and Opportunities in Quantum

Day 3 of DeepTechU featured advice for entrepreneurs developing deep tech innovations, a look at the current and future immunotherapy market, and a Fireside Chat about growing the quantum…

DeepTechU Day 2: Securing VC Funding and Federal Grants that ‘Take on the Risk that the Private Market Cannot’

The second day of DeepTechU featured practical advice for deep tech startups seeking funding, including when to start conversations with venture capitalists and how to use federal government grants…

DeepTechU Day 1: ‘The Innovation Ecosystem in the Chicago Area is Growing Beautifully – Go All In’

“We’re excited to unite the science and investor communities to advance innovation,” said Juan de Pablo, executive vice president for science, innovation, national laboratories, and global initiatives, kicking off…

50 Companies to Pitch to Investors at DeepTechU

The DeepTechU venture conference will showcase 50 startups during the three-day virtual event May 3 to 5, giving investors an early look at cutting-edge deep tech…

From Months to Weeks: Gene Delivery Method Improved with New ‘One-Step’ System

Delivered using adenovirus (Ad) vectors, therapeutic genes address the cause of disease – not just the symptoms. However, while advances in the understanding of human diseases and the genome have…
Load More Posts

This site uses cookies and other tracking technologies to assist with navigation and your ability to provide feedback, analyze your use of products and services, assist with our promotional and marketing efforts.

Accept